IPO Trending
VALIANTLABEQ / NSE, BSEListed

Valiant Laboratories Limited

Incorporated in 1980, Valiant Laboratories Limited is an Active Pharmaceutical Ingredient (API) manufacturing company in India primarily focused on producing Paracetamol. The company operates a manufacturing facility in Palghar, Maharashtra, spread across 2,000 sq. meters with a total installed annual capacity of 9,000 MT. Valiant Laboratories also has an in-house R&D facility equipped with an analytical laboratory and infrastructure to support development and improvement of existing products, strengthening its capabilities in the pharmaceutical ingredient space.

₹133 - ₹14029.75x sub
Listed Price162.15
Listing Gain+15.82%
TimelineBookbuilding IPO
Open27 Sep 2023
Close03 Oct 2023
Allotment04 Oct 2023
Listing06 Oct 2023

Quota Reservation Portions

RetailPortion: 38,11,500 shares
35%
Nii(hni)Portion: 16,33,500 shares
15%
QIBPortion: 54,45,000 shares
50%

Minimum Application Bracket Matrix

Retail1 lots / 105 shares
₹14,700
sHNI14 lots / 1,470 shares
₹2,05,800
bHNI69 lots / 7,245 shares
₹10,14,300

About the Company

Incorporated in 1980, Valiant Laboratories Limited is an Active Pharmaceutical Ingredient (API) manufacturing company in India primarily focused on producing Paracetamol. The company operates a manufacturing facility in Palghar, Maharashtra, spread across 2,000 sq. meters with a total installed annual capacity of 9,000 MT. Valiant Laboratories also has an in-house R&D facility equipped with an analytical laboratory and infrastructure to support development and improvement of existing products, strengthening its capabilities in the pharmaceutical ingredient space.

Company Promoters

Shantilal Shivji VoraDhanvallabh Ventures LLP (DVL)
Valiant Laboratories Limited IPO Details | GMP, Allotment & Financials | IPO Trending